FABRIS: "Norme per l'individuazione dei prodotti farmaceutici che producono effetti negativi sulla guida dei veicoli" (221)

This procedure concerns the establishment of standards to identify pharmaceutical products that can negatively impact a person's ability to drive a vehicle. It aims to improve road safety by clarifying which medications may impair cognitive or motor functions. This will primarily affect pharmaceutical manufacturers, healthcare providers, and drivers who use prescription or over-the-counter medications that could interfere with safe driving.